Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07722871
PHASE1
A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
This study compares and evaluates the bioequivalence of AD-116A and AD-1161 in healthy adult male volunteers under fed conditions.
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers Under Fed Conditions
Key Details
Gender
MALE
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-07
Completion Date
2026-10
Last Updated
2026-07-27
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-116A
Oral Capsule
DRUG
AD-1161
Oral Capsule
Locations (1)
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea